# Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

> **NCT01910519** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (actual)

## Conditions studied

- Influenza A Virus, H5N1 Subtype

## Interventions

- **BIOLOGICAL:** H5N1 vaccine plus AS03 adjuvant
- **BIOLOGICAL:** H5N1 vaccine without adjuvant

## Key facts

- **NCT ID:** NCT01910519
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-02
- **Final completion:** 2015-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01910519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01910519, "Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01910519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*